BackgroundInfection associated with implant-based breast reconstructive surgery is a nightmare for both patients and surgeons, often implying high recurrence rate, long treatments (both medical and surgical management), multiple invasive procedures, delay of the end-result and, in some cases, even reconstruction failure. Early diagnosis is crucial but not always easy to achieve. Different treatment options are available and have been described in literature, with no clear winning strategy. Recent improvements in microbiological and therapeutic tools have led the authors to question what would be considered the best plan for reconstruction salvage approach. MethodsAll patients undergoing implant-based breast reconstruction between 2012 and 2023 were enrolled. Clinical records regarding infections and treatment were retrospectively analyzed. ResultsAmong a total of 506 patients, 26 (5.14%) developed implant-associated infection. Discussing the results, we realized that previous protocol was old-fashioned and in need of improvements. Through a multidisciplinary approach, a new prevention and treatment algorithm was derived. Firstly, microbiological screening through nasal and rectal swab allows for proper decontamination prior to intervention. However, the keystone improvement consists in the use of molecular biology analysis, thus minimizing diagnosis timing and allowing targeted antibiotic therapy shortly after the removal of the infected implant. In addition, a fundamental role is played using instillation negative pressure wound therapy as a temporary spacer to ensure the maintenance of the peri-prosthetic pocket. ConclusionsFollowing precise steps, in case of implant-associated infection, the treatment can be optimized to reduce duration of both therapy and hospitalization, giving the patient a reconstruction in a relative short time. Level of EvidenceIV
Read full abstract